What is Brief History of CTS Company?

How did CTS evolve from telephone boxes to lunar-capable components?

CTS began in 1896 as the Chicago Telephone Supply Company, making wooden telephone hardware for Midwest exchanges. Over decades it shifted into sensors, actuators, and electronic components, serving medical, aerospace, defense, and EV markets worldwide.

CTS’s founders, A.J. Briggs and George A. Briggs, built a firm that moved from telephony to high-reliability components; its parts even reached the lunar surface, and by late 2025 the company’s market cap topped $1.4 billion.

What is Brief History of CTS Company? CTS started as a local telephone-supply maker in 1896 and transformed into a global electronic-components designer across multiple high-growth sectors — see CTS Porter's Five Forces Analysis.

Founded on September 28, 1896, CTS began as the Chicago Telephone Supply Company when A.J. Briggs and his son George A. Briggs moved to manufacture telephone sets and switchboards after the expiration of Bell’s patents, targeting independent telephone companies with high-quality, ornate wooden-cabinet equipment.

Founding Story

The Briggs family incorporated CTS in Chicago in 1896 to serve independent telephone operators; by 1902 they relocated to Elkhart, Indiana to lower costs and access a stable labor pool.

• Incorporated on September 28, 1896 in Chicago, Illinois
• Founded by A.J. Briggs and George A. Briggs to capitalize on post-patent market opportunities
• Initial products: complete telephone sets and switchboards in ornate wooden cabinets
• Relocated to Elkhart, Indiana in 1902 for lower operating costs and dedicated labor

The early CTS Company history shows modest private funding, hands-on mechanical assembly expertise, and rapid technical improvements driven by intense competition with the Bell System and other independents.

CTS Company timeline: incorporation in 1896, product focus on durable equipment for small telephone firms, strategic move in 1902, and gradual expansion of manufacturing capacity through the early 20th century, aligning with major developments in CTS Company history.

For more on strategy in later decades see Growth Strategy of CTS.

Complete CTS Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

The early growth and expansion of CTS Company saw rapid diversification from telephone parts into radio components in the 1920s, wartime production in the 1940s, and a postwar push into automotive electronics that reshaped its business by the 1970s and 1980s.

Radio-era diversification

In the 1920s CTS Company history records a strategic shift into variable resistors and volume controls for the booming radio market, becoming a leading supplier by 1930 and stabilizing revenues during the Great Depression.

Wartime manufacturing

During World War II CTS produced millions of crystal holders and military communication components, accelerating capabilities in precision miniaturization and ruggedized electronics for defense contracts.

Corporate rebranding and IPO

In 1960 the firm adopted the CTS Corporation name to reflect broader electronics activity and completed an initial public offering on the New York Stock Exchange in 1962, expanding access to capital for growth.

Automotive and global expansion

From the 1970s–1980s CTS accelerated into automotive electronics, introducing potentiometer-based throttle position sensors for major OEMs and establishing manufacturing in Taiwan, Mexico and Scotland to serve global demand.

The Evolution of CTS Company included measurable milestones: by the late 1980s CTS had transitioned from consumer-electronics components to a key supplier for automotive and industrial markets, with international plants and revenue diversification that reduced cyclical exposure; see related analysis at Target Market of CTS

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

CTS Company timeline highlights a century-long evolution from passive components to advanced piezoelectric materials, led by early Cermet resistor innovations in the late 1950s and recent pivots into medical ultrasound and EV sensing; milestones, innovations and challenges shaped a resilient R&D-led firm with R&D at 6.5% of revenue.

CTS innovation history centers on materials science and precision sensing, with a shift from passive resistors to piezoceramics enabling roles in surgical robotics and ultrasound imaging. Strategic acquisitions and sustained R&D investment, currently about 6.5% of revenue, underpin product leadership in high-performance components.

Cermet Resistors

Late-1950s development of Cermet resistors set industry reliability benchmarks for aerospace and military electronics.

Piezoelectric Materials

Acquisition of Ferroperm in 2022 expanded CTS's piezoceramic portfolio for ultrasound and precision actuation.

Medical Ultrasound Components

High-performance piezo materials supplied to OEMs improved image resolution and device miniaturization.

EV Sensor Development

Introduced brake position sensors and thermal actuators in 2024–2025 to capture EV powertrain and thermal control demand.

Precision Actuators

Engineered compact thermal management actuators for automotive and industrial applications to improve system efficiency.

R&D Investment

Maintains R&D at roughly 6.5% of annual revenue to align with megatrends like surgical robotics and vehicle electrification.

CTS navigated severe market shocks—the dot-com crash and the 2008 crisis—forcing restructuring and sharper focus on profitable engineering. Recent supply-chain disruption and rapid EV adoption required accelerated product development and supplier diversification.

Market Downturns

Dot-com collapse and 2008 financial crisis led to revenue declines and prompted major cost restructuring to preserve cash flow.

Supply-Chain Volatility

Global component shortages in 2021–2024 required supplier diversification and inventory strategy changes to maintain production.

Commoditization Pressure

2013 EMS divestiture addressed margin erosion by refocusing on differentiated component engineering and materials IP.

Technology Transition

Shift toward piezoceramics and EV sensors required capital allocation to scale production and qualify components for automotive standards.

Regulatory & Quality Demands

Serving medical and automotive markets increased certification costs and extended product validation cycles to meet safety standards.

Strategic Alignment

Leadership aligned innovation roadmap to megatrends, converting competitive threats into growth in surgical robotics and EV electrification.

For additional context on corporate strategy and market positioning, see Marketing Strategy of CTS

CTS Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Timeline and Future Outlook: a concise chronology from the 1896 founding to 2025 expansion into EV actuators, and a forward-looking view to 2026+ focusing on medical, aerospace, automation and electrification.

Market positioning

CTS’s portfolio aligns with global electrification trends; medical and aerospace segments offer higher ASPs and recurring revenue from certified components.

M&A and capital allocation

Active M&A pipeline targets high-precision sensing and piezoelectric technologies to accelerate growth and margin expansion.

R&D and product roadmap

Investment in EV actuators and medical-grade sensors supports projected revenue growth; R&D spend historically near industry peers at mid-single-digit percent of sales.

Financial outlook

Analysts forecast steady revenue growth through 2026 driven by electrification and medical demand; balance sheet strength supports capex and acquisitions. See related analysis in Competitors Landscape of CTS

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE